173 Deputy Maureen O’Sullivan asked the Minister for Health and Children if she will comment on the assertion that the switching of medications from a branded drug such as fosamax or actonel, for treatment of osteoporosis, to generic alendronate is a false economy as research has shown that persons who were switched to a cheaper version of a generic drug did not show any improvement in their bone density and that patients had side effects with the cheaper generic drug. [21548/10]

Summary

173 Deputy Maureen O’Sullivan asked the Minister for Health and Children if she will comment on the assertion that the switching of medications from a branded drug such as fosamax or actonel, for treatment of osteoporosis, to generic alendronate is a false economy as research has shown that persons who were switched to a cheaper version of a generic drug did not show any improvement in their bone density and that patients had side effects with the cheaper generic drug. [21548/10]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 25 May 2010

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.